LIF and the lung’s stem cell niche: is failure to use LIF to protect against COVID-19 a grave omission in managing the pandemic?
Published version
Peer-reviewed
Repository URI
Repository DOI
Change log
Authors
Abstract
Tweetable abstract: What tips the SARS/COVID-19 balance into severe pneumonia, rather than recovery? Is it insufficient LIF – the lung’s own protective growth factor at the blood–air barrier?
Description
Keywords
Is Part Of
Publisher
Future Medicine Ltd
Publisher DOI
Rights and licensing
Except where otherwised noted, this item's license is described as Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)